Abstract |
Autophagy, the major lysosomal pathway for recycling intracellular components including organelles, is emerging as a key process regulating tumorigenesis and cancer therapy. Most recently, we newly synthesized folate-appended methyl-β- cyclodextrin (FA-M-β-CyD), and demonstrated the potential of FA-M-β-CyD as a new antitumor drug. In this study, we investigated whether anticancer activity of FA-M-β-CyD in folate receptor-α (FR-α)-positive tumor cells is involved in autophagy. In contrast to methyl-β- cyclodextrin (M-β-CyD), FA-M-β-CyD entered KB cells (FR-α (+)) through CLIC/GEEC endocytosis. No significant depression in the DNA content was observed in KB cells after treatment with FA-M-β-CyD. Additionally, the transmembrane potential of mitochondria after treatment with FA-M-β-CyD was drastically elevated. Meanwhile, FA-M-β-CyD induced the formation of autophagic vacuoles, which were partially colocalized with mitochondria, in KB cells. Taken together, these results suggest that FR-α-expressing cell-selective cytotoxic activity of FA-M-β-CyD could be mediated by the regulation of autophagy, rather than the induction of apoptosis.
|
Authors | Risako Onodera, Keiichi Motoyama, Nao Tanaka, Ayumu Ohyama, Ayaka Okamatsu, Taishi Higashi, Ryusho Kariya, Seiji Okada, Hidetoshi Arima |
Journal | Scientific reports
(Sci Rep)
Vol. 4
Pg. 4417
(Mar 20 2014)
ISSN: 2045-2322 [Electronic] England |
PMID | 24646866
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Folate Receptor 1
- Ligands
- beta-Cyclodextrins
- methyl-beta-cyclodextrin
- Folic Acid
|
Topics |
- Antineoplastic Agents
(chemical synthesis, pharmacology)
- Autophagy
(drug effects)
- Folate Receptor 1
(genetics, metabolism)
- Folic Acid
(chemistry)
- Gene Expression
- Humans
- KB Cells
- Ligands
- Protein Binding
- beta-Cyclodextrins
(chemical synthesis, pharmacology)
|